Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes
2020 ◽
Vol 132
(4)
◽
pp. 337-345
◽
Ildiko Lingvay
◽
Nadine Beetz
◽
Regina Sennewald
◽
Annette Schuler-Metz
◽
Julia Bertulis
◽
...
M G Bubnova
◽
D M Aronov
◽
Marina Bubnoa
◽
David Aronov
2020 ◽
Vol 69
(Supplement 1)
◽
pp. 135-OR
ELENI PAPPA
◽
CHRISTINA KOSTARA
◽
CONSTANTINOS TELLIS
◽
ALEXANDROS D. TSELEPIS
◽
ELENI BAIRAKTARI
◽
...
V Ophascharoensuk
◽
K Phimda
2010 ◽
Vol 2
◽
pp. 201-215
2020 ◽
Vol 22
(6)
◽
pp. 1001-1005
Niki Katsiki
◽
Richard Ofori‐Asenso
◽
Ele Ferrannini
◽
Mohsen Mazidi
2013 ◽
Vol 14
(4)
◽
pp. 361-370
◽
Yuri Ono
◽
Hiraku Kameda
◽
Kyu Yong Cho
2010 ◽
Vol 119
(02)
◽
pp. 63-68
◽
N. P. E. Kadoglou
◽
A. Kapelouzou
◽
H. Tsanikidis
◽
I. Vitta
◽
C. Liapis
◽
...
2016 ◽
Vol 19
(7)
◽
pp. A667
I Daacke
◽
S Kanters
◽
K Thorlund
◽
A Tebboth
2010 ◽
Vol 19
(8)
◽
pp. 1017-1025
◽
Clifford J Bailey
◽
Brian D Green
◽
Peter R Flatt